Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment
Open Journal of Rheumatology and Autoimmune Diseases · 2012
DOI: 10.4236/ojra.2012.22003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Journal of Rheumatology and Autoimmune Diseases, 2012. Verfasst von Deana D Hoganson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Mayo Clinic, Rochester. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Rheumatology, Mayo Clinic, Rochester.
- Department of Radiology, Mayo Clinic, Rochester, MN.
- Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
- Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
- Division of Rheumatology, Mayo Clinic, Rochester ; Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
Förderung
- NIBIB NIH HHS
Zitieren
APA
Hoganson, D. D., Chen, J., Ehman, R. L., Talwalkar, J. A., Michet, C. J., Yin, M., Crowson, C. S., & Matteson, E. L. (2012). Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment. Open Journal of Rheumatology and Autoimmune Diseases. https://doi.org/10.4236/ojra.2012.22003
Vancouver
Hoganson DD, Chen J, Ehman RL, Talwalkar JA, Michet CJ, Yin M, et al. Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment. Open Journal of Rheumatology and Autoimmune Diseases. 2012. doi:10.4236/ojra.2012.22003
BibTeX
@article{Hoganson2012,
author = {Hoganson, Deana D and Chen, Jun and Ehman, Richard L and Talwalkar, Jayant A and Michet, Clement J and Yin, Meng and Crowson, Cynthia S and Matteson, Eric L},
title = {Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment},
journal = {Open Journal of Rheumatology and Autoimmune Diseases},
year = {2012},
doi = {10.4236/ojra.2012.22003}
}
EUVIMED